Table of Contents Table of Contents
Previous Page  586 / 1631 Next Page
Information
Show Menu
Previous Page 586 / 1631 Next Page
Page Background

A Phase III Efficacy and Safety Study of the Proposed Rituximab

Biosimilar GP2013 versus Rituximab in 629 Patients with

Previously Untreated Advanced Follicular Lymphoma

79

1 … 581 582 583 584 585 586 587 588 589 590 591 592 … 1631  FlippingBook